Critical Issues in Delivery of RNAi Therapeutics In Vivo

E-ISSN： 1873-4316|13|7|1279-1291

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.7, 2012-06, pp. : 1279-1291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Delivery In Vivo of siRNA-Based Therapeutics

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3603-3619

Bentham Science Publishers

Access to resources Recommend Favorite

Chemical Modifications of Synthetic RNAi Agents and in vivo Delivery Techniques

Current Bioactive Compounds, Vol. 4, Iss. 1, 2008-06 ,pp. : 6-14

Bentham Science Publishers

Access to resources Recommend Favorite

RNAi extravaganza: from biochemistry to drugs and therapeutics

By Appasani Krishnarao

Pharmacogenomics, Vol. 8, Iss. 8, 2007-08 ,pp. : 889-893

Future Medicine

Access to resources Recommend Favorite

Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics

By Keates Andrew C Fruehauf Johannes H Xiang Shuanglin Parker Peter D Li Chiang J

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 867-871

Future Medicine

Access to resources Recommend Favorite

The Design of Vectors for RNAi Delivery System

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1327-1340

Bentham Science Publishers

Access to resources Recommend Favorite